Avinger Inc (AVGR)

[x1power]

This is super news for us retail investors.
It can help to encourage company and our EU sales and potential USA FDA process. We have boldly taken a step forward by thus achieving our product
enhancements and operative data to further smoothed the way for FDA 'considerations'.


The next news Jan 12 S1 carries company finances forward for 9 months of 2018 and also sets us up for R/Spilt. Its a straight coin toss where we go from here.

Medtronic is our domestic USA major competitor and patent potential challenge source. Will they remain silent and watch to see how our products do, or . . . offer a take-over, etc.?
They would be most wise to buy up 10-20% of our shares and ask for 1-2 BOD seats, and thus avoid other competitors from taking over AVGR? And, thus
to achieve control of our techs and yet to have so avoided SEC activity barrier 'trip' legality issues step-in?

I have feeling R/S is not far away to transpire.